Back to User profile » Dr Weiping Xie
Papers published by Dr Weiping Xie:
Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer
Huang W, Liu P, Zong M, Chen QQ, Zhou H, Kong H, Xie WP
Cancer Management and Research 2021, 13:4299-4307
Published Date: 31 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
Liu P, Huang W, Ding Y, Wu J, Liang Z, Huang Z, Xie W, Kong H
Drug Design, Development and Therapy 2021, 15:1653-1666
Published Date: 22 April 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition
Yu M, Peng L, Liu P, Yang M, Zhou H, Ding Y, Wang J, Huang W, Tan Q, Wang Y, Xie W, Kong H, Wang H
Drug Design, Development and Therapy 2020, 14:1191-1202
Published Date: 19 March 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients
Shi W, Wu J, Tan Q, Hu CM, Zhang X, Pan HQ, Yang Z, He MY, Yu M, Zhang B, Xie WP, Wang H
Infection and Drug Resistance 2019, 12:1265-1276
Published Date: 14 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib
Fang SC, Huang W, Zhang YM, Zhang HT, Xie WP
OncoTargets and Therapy 2019, 12:985-992
Published Date: 1 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
Fang S, Zhang H, Zhang Y, Xie W
OncoTargets and Therapy 2017, 10:447-452
Published Date: 18 January 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Small pulmonary vascular alteration and acute exacerbations of COPD: quantitative computed tomography analysis
Wang Z, Chen X, Liu K, Xie W, Wang H, Wei Y, Tang L, Zhu Y
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1965-1971
Published Date: 22 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension
Chen X, Liu K, Wang Z, Zhu Y, Zhao Y, Kong H, Xie W, Wang H
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2525-2533
Published Date: 18 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion
Xu H, Hou Z, Zhang H, Kong H, Li X, Wang H, Xie W
International Journal of Nanomedicine 2014, 9:231-242
Published Date: 27 December 2013